ArticleslgStudy

chemistry

N-Arachidonoyl dopamine

N-Arachidonoyl dopamine is a chemistry topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand N-Arachidonoyl dopamine rather than just read about it. In short: N-Arachidonoyl dopamine (NADA) is an endocannabinoid that acts as an agonist of the CB1 receptor and the transient receptor potential V1 (TRPV1) ion channel. NADA was first described as a putative endocannabinoid (agonist for the CB1 receptor) in 2000 and was subsequently identified as an endovanilloid (agonist for TRPV1) in 2002.

N-Arachidonoyl dopamine — main illustration
N-Arachidonoyl dopamine — illustration

Key takeaways

  • N-Arachidonoyl dopamine belongs to chemistry; place it in that map before memorising details.
  • Learn the definition first, then one example that makes the definition concrete.
  • Connect N-Arachidonoyl dopamine to a quantity you can measure, compute or draw — that is where exam questions come from.
  • Reproduce the core statement of N-Arachidonoyl dopamine from memory before moving on to harder problems.

Reference excerpt

N-Arachidonoyl dopamine (NADA) is an endocannabinoid that acts as an agonist of the CB1 receptor and the transient receptor potential V1 (TRPV1) ion channel. NADA was first described as a putative endocannabinoid (agonist for the CB1 receptor) in 2000 and was subsequently identified as an endovanilloid (agonist for TRPV1) in 2002. NADA is an endogenous arachidonic acid based lipid found in the brain of rats, with especially high concentrations in the hippocampus, cerebellum, and striatum. It activates the TRPV1 channel with an EC50 of approximately of 50 nM which makes it the putative endogenous TRPV1 agonist. In mice, NADA was shown to induce the tetrad of physiological paradigms associated with cannabinoids: hypothermia, hypo-locomotion, catalepsy, and analgesia. NADA has been found to play a regulatory role in both the peripheral and central nervous systems, and displays antioxidant and neuroprotectant properties. NADA has also been implicated in smooth muscle contraction and vasorelaxation in blood vessels. Additionally, NADA has been observed to suppress inflammatory activation of human Jurkat T cells and to inhibit the release of prostaglandin E2 (PGE2) from lipopolysaccharide (LPS)-activated astrocytes, microglia and mouse brain ECs (MEC-Brain). NADA also promotes the resolution of inflammation in human endothelial cells activated by both endogenous (i.e. TNF) and exogenous (i.e. bacterial derived LPS (TLR4 agonist) and FSL-1 (Fibroblast-Stimulating Lipopeptide, TLR2 and TLR6 agonist)) inflammatory mediators. It can increase the TRPV1-mediated release of substance P and calcitonin gene-related peptide (CGRP) in rat dorsal spinal cord slices. Furthermore, NADA also displays inhibitory activity in HIV-1 replication assays. Finally, NADA can prevent the degranulation and release of TNF from RBL- 2H3 (Rodent Basophilic Leukemia; Histamine Releasing, Group 3) mast cells treated with an IgE-antigen complex. Together, these studies show that physiological functions attributed to NADA are multifaceted, and include the ability to modulate the immune response. The biosynthetic pathway of N-arachindonoyl dopamine is not well understood. It has been proposed to be conjugated from arachidonoyl-CoA or arachidonoyl phospholipids and dopamine, but in vitro experiments do not support this theory. However, the indirect biosynthesis of phospholipid esters with dopamine may be possible, as dopamine can induce the aminolysis of the glycerol-fatty acid bonds in phospholipid chains (arachidonoyl, palmitoyl, linoleyl, etc.).

See also Endocannabinoid Phospholipase A2

References

External links General information about NADA.

Illustrations

N-Arachidonoyl dopamine illustration
N-Arachidonoyl dopamine illustration

Worked examples

Example 1 — a first encounter with N-Arachidonoyl dopamine

Start with the simplest possible case. Write down what N-Arachidonoyl dopamine claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In chemistry, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to N-Arachidonoyl dopamine before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about N-Arachidonoyl dopamine ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of N-Arachidonoyl dopamine

In research
N-Arachidonoyl dopamine appears in chemistry research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry
Engineering practice reuses N-Arachidonoyl dopamine in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom
N-Arachidonoyl dopamine is common in secondary-school and first-year university syllabi. It links to neighbouring topics Arachidonyl compounds, CB1 receptor agonists, Catecholamines, so understanding it makes those chapters shorter.
In everyday life
Look for N-Arachidonoyl dopamine outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.
Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “N-Arachidonoyl dopamine” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study N-Arachidonoyl dopamine in 20 minutes

  1. Read the reference excerpt below once, without taking notes.
  2. Close the page and write down what N-Arachidonoyl dopamine means in your own words.
  3. Compare your version with the excerpt and mark what you missed.
  4. Work through the three examples above with pen and paper.
  5. Explain N-Arachidonoyl dopamine out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is N-Arachidonoyl dopamine in simple terms?

N-Arachidonoyl dopamine (NADA) is an endocannabinoid that acts as an agonist of the CB1 receptor and the transient receptor potential V1 (TRPV1) ion channel. NADA was first described as a putative endocannabinoid (agonist for the CB1 receptor) in 2000 and was subsequently identified as an endovanil…

Why does N-Arachidonoyl dopamine matter?

Because it connects several chemistry ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study N-Arachidonoyl dopamine?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on N-Arachidonoyl dopamine.

Tags

  • Arachidonyl compounds
  • CB1 receptor agonists
  • Catecholamines
  • Eicosanoids
  • Endocannabinoids
  • Fatty acid amides
  • Vanilloids

Keep exploring